Acetylsalicylic acid consumption in patients with diabetes mellitus;Consumo de ácido acetilsalicílico en pacientes con diabetes mellitus

Medicina Clinica

Volumn 122, Issue 3, 2004, Pages 96-98

  Esmatjes, Enric ^a,b   Castell, Conxa ^c   Franch, Josep ^d   Puigoriol, Emma ^b   Hernáez, Rubén ^b  

^a Societat Catalana de Cirurgia   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Consell Assesor Diabet Catalunya ^*  (Spain)

^d GEDAPS   (Spain)

Author keywords

Acetylsalicylic acid; Aspirin; Cardiovascular disease; Diabetes mellitus; Primary prevention; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DRUG USE; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIMARY PREVENTION; SECONDARY PREVENTION; SPAIN;

EID: 1442278401     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13056809     Document Type: Article

References (10)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
2. American Diabetes Association. Aspirin therapy in diabetes (Position Statement). Diabetes Care 1997;20:1767-71.
3. Caims JA. Antithrombotic agents in coronary artery disease. Sixth ACCCP Consensus Conference on antithrombotic therapy. Chest 2001;119:228S-52S.
4. Rolka DB, Fagot-Campagna A, Narayan KMV. Aspirin use among adults with diabetes. Diabetes Care 2001;24:197-201.
5. Krein SL, Vijan S, Pogach LM, Hogan MM, Keer EA. Aspirin use and counseling about aspirin among patients with diabetes. Diabetes Care 2002;25:965-70.
6. Wood DM, Plehwe WE, Colman PG. Aspirin usage in a large teaching hospital diabetes clinic setting. Diabet Med 1999;16:605-8.
7. ETDRS Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 1992;268:1292-300.
8. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmefeld D, Julius S, et al. Effects of intensive blood-pressure lowering and low dose aspirin on patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998;351:1755-62.
9. Peto R, Gray R, Collins R, Wheatley K, Hennekens C, Jamrozik K et al. Randomised trial of prophylactic daily aspirin in British male doctors. BMJ 1988;296:313-6.
10. Steering Committee of the Physicians Health Study Research Group. Final report on aspirin component of the ongoing physicians' health study. N Engl J Med 1989;321:129-35.